Valuation: Kenvue Inc.

Market Cap 36.61B 31.36B 29.34B 26.86B 50.41B 3,503B 51.07B 347B 135B 1,760B 137B 134B 5,820B P/E 2026 *
20x
P/E 2027 * 17.4x
Enterprise Value 43.66B 37.4B 34.99B 32.03B 60.12B 4,177B 60.91B 413B 161B 2,098B 164B 160B 6,941B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.7x
Free-Float
98.88%
Yield 2026 *
4.44%
Yield 2027 * 4.52%
1 day+0.69%
1 week-0.73%
Current month-0.94%
1 month-0.37%
3 months+8.73%
6 months+1.82%
Current year+10.49%
1 week 18.74
Extreme 18.735
19.18
1 month 18.65
Extreme 18.65
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.63
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%-0.73%-11.80%-19.71% 36.61B
+1.20%+0.09%-8.82%-4.71% 336B
+0.69%+1.99%-10.75%+5.03% 137B
+1.54%-0.95%+5.98%+23.90% 72.61B
-0.64%-2.99%-23.38%-21.47% 49.48B
+6.02%+18.40%+11.74%-31.85% 36.88B
+1.20%+1.63%-20.05%-33.19% 20.26B
+0.08%+0.65%+5.27%+26.80% 20.24B
+0.11%-1.69%+7.13%+8.79% 19.58B
-1.48%-0.14%-25.79%-10.07% 9.98B
Average +0.94%+1.53%-7.05%-5.65% 73.93B
Weighted average by Cap. +1.13%+0.57%-7.55%-2.94%

Financials

2026 *2027 *
Net sales 15.6B 13.36B 12.5B 11.44B 21.47B 1,492B 21.76B 148B 57.59B 750B 58.56B 57.29B 2,479B 15.97B 13.68B 12.8B 11.71B 21.99B 1,528B 22.28B 151B 58.96B 767B 59.96B 58.65B 2,538B
Net income 1.83B 1.57B 1.47B 1.34B 2.52B 175B 2.55B 17.33B 6.76B 87.96B 6.87B 6.72B 291B 2.11B 1.81B 1.69B 1.55B 2.91B 202B 2.95B 20B 7.8B 102B 7.93B 7.76B 336B
Net Debt 7.05B 6.04B 5.65B 5.17B 9.71B 675B 9.84B 66.76B 26.04B 339B 26.47B 25.9B 1,121B 6.57B 5.63B 5.27B 4.82B 9.05B 629B 9.17B 62.23B 24.27B 316B 24.67B 24.14B 1,045B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-21 US$19.06 +0.69% 13,572,635
26-08-20 US$18.93 -1.05% 17,706,411
26-08-19 US$19.13 +1.76% 36,188,250
26-08-18 US$18.80 +0.05% 25,521,737
26-08-17 US$18.79 -2.14% 27,969,749
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.06USD
Average target price
19.50USD
Spread / Average Target
+2.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock